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Hydatidiform mole or molar pregnancy is a benign Gestational 
Trophoblastic Disease (GTD) that originates from the placenta. 
Treatment consists of vacuum evacuation but rarely hysterectomy 
may be required. One common complication of molar pregnancy 
is hyperthyroid. Anesthetic management is often complicated by 
the associated systemic complications. These complications cannot 
be prevented, but with a better understanding of the disease, some 
measurements to avoid maternal mortality can be performed. 
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INTRODUCTION
A hydatidiform mole is a gestational trophoblas-
tic disease that originates from the placenta. It 
is a rare but life-threatening disorder. Human 
Chorionic Gonadotrophin (hCG) present in the 
human placenta is identical with the a-subunit of 
the Thyroid-Stimulating Hormone (TSH) but has 
a weak thyroid-stimulating activity during normal 
pregnancy.1
The human placenta contains two thyrotrophic 
substances. One, called human chorionic gonadotro-
pin, has a weak intrinsic thyroid-stimulating activity 
in normal pregnancy. The other, molar thyrotropin, 
is extracted from the tumor and serum of the patient 
with hydatidiform mole and differs from hCG by 
being larger in molecular size and longer in the dura-
tion of action. These substances, elaborated by the 
gestational trophoblastic tissue, are responsible for 
thyrotoxicosis observed in patients with the tropho-
blastic tumor. Clinical hyperthyroidism due to 
trophoblastic disease is cured by evacuation of 
molar tissue.2
In this article, we report the anesthetic manage-
ment of a patient who developed hyperthyroidism 
during molar pregnancy and was scheduled for 
evacuation.
CASE REPORT
The case took place at H.L. Manambai Abdul 
Kadir Hospital at Sumbawa Besar regency, which is 
8 hours away from nearest referral hospital. A 60 kg, 
25 years old woman with 14-15 weeks of molar 
pregnancy was scheduled for suction curettage. She 
was first admitted for vaginal bleeding that kept 
going during her stay at the hospital. Ultrasound 
examination revealed molar pregnancy. She was 
also feeling weak and experiencing palpitations. 
BP was 150/100 mmHg, and HR was 124  bpm. 
Hemoglobin level upon admission was 9.5 g/dL 
(Hematocrit 28.6%, platelet 191.000/mm3). TSH 
level was <0.005 µIU/mL, and FT4 was 4.83 ng/dL. 
Liver and kidney function tests were unremarkable. 
Internal medicine consultation suggests that 
she is currently showing no emergency indications 
for surgery, that the thyroid function tests must be 
optimized first. She received PTU 100 mg QID, 
propranolol 10 mg TID, and dexamethasone IV 
5 mg TID. She was then observed for 24 hours.
After 18 hours, her CBC revealed a significant 
drop in hemoglobin level (9.5 to 7.6 g/dL) due to 
continuous vaginal spotting. Blood transfusion 
was ordered. She was then consulted to anesthe-
tist for emergency evacuation under anesthesia. 
Anesthesia preparations include NG tube, PTU, 
propranolol oral, ice packs, and dexamethasone. 
Intravenous beta blocker and paracetamol were not 
available in this hospital.
She was prepared for the intrathecal block. 
Consent was obtained after explaining risks due to 
thyrotoxicosis. We administered midazolam 2 mg 
IV, dexamethasone 20 mg IV, and ondansetron 
4 mg IV as pre-medications. Monitoring included 
pulse oximetry, ECG, and noninvasive blood 
pressure measurement. Vital signs upon arrival at 
OR were BP 130/90 mmHg, PR 118 bpm, RR 18 
breaths per minute, axillary temperature 37.2 °C, 
and VAS 20-30 mm. Spinal anesthesia was done in 
left lateral position at L3-L4 level, with Bupivacaine 
0.5% 10 mg. The level of block was extended until 
T10 level. 
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Suction curettage was performed in about 
30 minutes with acceptable blood loss (<500 mL). 
No remarkable events happened during the proce-
dure. Postoperatively the patient was transferred 
back to the ward with Paracetamol 750 mg QID as 
analgetic. Blood transfusion was given in the ward.
DISCUSSION
The treatment of hydatidiform mole is a surgical 
evacuation. Serious morbidity and even mortality 
can be seen if no precautionary measures are taken 
during the evacuation of the molar pregnancy. 
Thyrotoxicosis, anemia, and dehydration due to 
bleeding aggravate cardiac dysfunction and respi-
ratory insufficiency.1 Epidemiologic studies have 
reported wide regional variations in the incidence 
of hydatidiform mole. Hydatidiform pregnancy 
occurs in 1:1000 pregnancies worldwide. Incidence 
is higher in Asian countries.3 
Trophoblastic hyperthyroidism should alert the 
anesthesiologist to a potentially life-threatening 
situation. Kim et al in 1976 reported such a case 
in which hyperthyroidism progressed to thyroid 
storm after an emergency evacuation of the mole.2 
Hydatidiform mole refers to an abnormal 
pregnancy characterized by varying degrees of 
trophoblastic proliferation (both cytotrophoblast 
and syncytiotrophoblast) and vesicular swelling 
of placental villi associated with an absent or 
an abnormal fetus/embryo. Complete hydatidi-
form mole most commonly presents with vaginal 
bleeding, usually occurring at 6-16 weeks of gesta-
tion in 80-90% of cases. The other classic clinical 
signs and symptoms include uterine enlargement 
greater than expected for gestational dates (28%), 
hyperemesis (8%), and pregnancy-induced 
hypertension in the first or second trimester (1%).4 
Ultrasonography and increased hCG levels play 
a critical role in the diagnosis of both complete 
and partial moles. Ultrasonography has virtually 
replaced all other means of preoperative diagnosis. 
Approximately 50% of patients with complete mole 
have pre-evacuation hCG levels 100,000 mIU/mL. 
A single hCG determination, however, is seldom 
helpful in differentiating complete mole from a 
normal intrauterine pregnancy, multiple gestations, 
or a pregnancy complicated by diseases such as 
erythroblastosis fetalis or intrauterine infections.4
Complications associated molar pregnancy 
should be well known by the anesthesiologist. They 
include acute pulmonary distress, hyperthyroidism 
with potential for thyroid storm, severe anemia, 
pregnancy-induced hypertension, trophoblastic 
emboli, malignant neoplasm, hyperemesis grav-
idarum, disseminated intravascular coagulation, 
hemorrhage, and ovarian theca lutein cysts.5
Burch-Wartofsky Score is commonly used to 
predict the likeliness of thyroid storm to happen.6 A 
score below 25 indicates an unlikeliness, and score 
above 45 indicates the likeliness of thyroid storm 
to happen. Score between 25 and 45 indicates an 
impending thyroid storm. Parameters used for 
this score include body temperature, CNS status, 
gastrointestinal-hepatic dysfunction, cardiovascu-
lar function, the presence of congestive heart fail-
ure, and precipitative history. 
Anemia in molar pregnancy is mostly second-
ary to chronic occult per vaginal bleeding. Severe 
anemia can lead to left ventricular failure leading 
to cardiopulmonary distress. An inadvertent fluid 
overload could occur during a central neurax-
ial block in an attempt to sustain blood pressure. 
Careful fluid administration should be applied to 
prevent inadvertent fluid overload.7
This patient showed the classic manifestation 
of molar pregnancy, with the presence of vaginal 
spotting, anemia, and hyperthyroid symptoms. 
Ultrasound examination confirms obstetrician’s 
suspicion of molar pregnancy. The clinical mani-
festations of hyperthyroidism are due to the high 
serum levels of circulating hCG and Thyrotropin 
in the plasma of such patients.8 Hyperthyroidism 
should be controlled pre-operatively whenever 
possible. In the thyrotoxic patient, anti-thyroid 
medication, b blockers and supportive measures 
such as fluid resuscitation are necessary to mini-
mize the risk of precipitating thyroid storm.9
Perioperative management of hyperthyroidism 
focuses on the control of the sympathetic activity so 
that cardiovascular side effects are not manifested. 
Because blood loss may be substantial at surgery, 
appropriate blood products should be available.2 
The patient should be immediately put on anti-thy-
roid drugs to achieve euthyroid. Propylthiouracil 
(PTU) and methimazole work by inhibiting 
thyroid hormone synthesis. Beta-blockers, in this 
case, propranolol, ameliorate actions of T3 and 
T4 in tissues and also inhibit adrenergic effects. 
Iodides (lugol, potassium iodide) block thyroid 
hormone release, inhibit both T3 and T4 formation 
and decrease thyroid gland size. Steroids inhibit 
the conversion of T4 to T3 and decrease TSH 
release. However, it may take days or sometimes 
weeks before the patient achieve euthyroid status. 
Nevertheless, in our case, antithyroid medication 
was given preoperatively even though its effect may 
only be beneficial after surgery.
Communication between anesthetist and obste-
trician ideally should begin soon after the diagnosis 
of molar pregnancy has been established to provide 
adequate time for a comprehensive preoperative 
workup. Particular emphasis is placed on patient’s 
cardiopulmonary status, electrolyte abnormality, 
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coagulation status, and oxygen-carrying capacity.5 
Preoperative laboratory tests should include CBC, 
coagulation study, electrolyte, thyroid function 
tests, and chest radiograph. Arterial blood gas 
should be taken should the patient possess signs or 
symptoms of pulmonary edema. 
Thyroid storm is a life-threatening emergency 
which is usually encountered in 2-4% patients in 
the postoperative period.8 Anesthetist must be 
familiar with the symptoms of a thyroid storm. 
Marked elevation of body temperature, tachycardia, 
chest pain, shortness of breath, anxiety, and irrita-
bility, excessive sweating, arrhythmias, pulmonary 
edema and congestive cardiac failure may present. 
If unrecognized the condition is invariably fatal. 
Combined use of anti-thyroid drugs, β-blockers, 
and corticosteroids restores serum T3 concentra-
tion to within normal range within 24 to 48 hours. 
Paracetamol, combined with internal and external 
cooling, may be helpful in alleviating hyperpyrexia. 
In the absence of cardiac insufficiency, β-block-
ers to ameliorate symptoms should be started 
preoperatively.
The common anesthetic technique for surgi-
cal procedures for evacuating molar pregnancy 
suggests that general anesthesia as the technique 
of choice.5 Invasive monitoring is recommended 
for uterus size greater than 16 weeks, decreased 
PaO2, evidence of pulmonary edema, severe preg-
nancy-induced hypertension, and thyrotoxicosis. 
However, uterine relaxation caused by certain 
inhaled anesthetics may further increase blood loss. 
Therefore, inhaled anesthetics with known toco-
lytic qualities, such as halothane, enflurane, and 
isoflurane, should be used in low concentrations
In our case, we preferred to use regional anes-
thesia. The sympathetic block induced by spinal 
anesthesia can be helpful. It also avoids the tocolytic 
effect of volatile anesthesia. The patient was calm 
and cooperative, so the technique was considered 
relatively easy. It can also avoid the effects of venti-
lation on the pulmonary system. And because the 
patient was somewhat alert, complications like 
thyroid storm and cardiopulmonary distress can be 
detected earlier compared to general anesthesia.
Laurent et al administered propranolol, a 
long-acting β1, and β2 blocker before and after 
surgery to control sympathetic activation. Esmolol, 
a short-acting β1 blocker, has also been used to 
attenuate the hemodynamic response to laryngos-
copy and intubation in patients with pregnancy-in-
duced hypertension.9
The patient was discharged two days after the 
procedure with no known complications. Anti-
thyroid medications were continued and she will be 
evaluated periodically by an internist. 
CONCLUSION
Anesthetists should be well aware of perioperative 
complications associated with molar pregnancy. 
Pre-anesthesia workup, pre-operative optimization, 
and well-thought anesthesia technique of choice are 
mandatory for any case of molar pregnancy. 
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